Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:estradiol
gptkb:relugolix gptkb:norethindrone_acetate |
| gptkbp:approvalYear |
2021
|
| gptkbp:ATCCode |
gptkb:G03HB08
|
| gptkbp:contraindication |
pregnancy
history of thromboembolic disorders undiagnosed abnormal uterine bleeding |
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Myfembree
|
| gptkbp:manufacturer |
gptkb:Pfizer
gptkb:Myovant_Sciences |
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
fatigue
headache hot flush irregular uterine bleeding |
| gptkbp:usedFor |
management of moderate to severe pain associated with endometriosis
management of heavy menstrual bleeding associated with uterine fibroids |
| gptkbp:bfsParent |
gptkb:Myovant_Sciences
|
| gptkbp:bfsLayer |
6
|